Skip to content

Acute Myeloid Leukemia Mll Gene Rearrangement Cn305562

Published: July 22, 2026Updated: August 25, 2026

AML with MLL gene rearrangement involves a genetic change that affects blood cell development. It commonly affects infants and younger patients. Prognosis depends on the specific rearrangement.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Recurrent infections

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Hepatosplenomegaly

(hepatic)

Weight loss

(metabolic)

Lymphadenopathy

(lymphatic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Intensive Multi-Agent Chemotherapy

Aggressive cytarabine and anthracycline-based induction followed by consolidation for MLL rearranged AML, which has high proliferative index. May include additional agents targeting specific molecular pathways.

medication
3

Allogeneic Stem Cell Transplantation

Donor stem cell transplant performed in first complete remission for MLL rearranged AML given its high relapse risk. Provides graft-versus-leukemia effect critical for disease control.

procedure

Additional treatment options

Targeted Epigenetic Therapy

Demethylating agents such as azacitidine or decitabine may be used alone or in combination, particularly in older patients unsuitable for intensive chemotherapy with MLL rearranged disease.

medication

Molecular MRD Surveillance

Regular PCR or NGS-based monitoring for MLL gene rearrangements to detect impending relapse early. Allows for preemptive intervention strategies.

monitoring

Child and Family-Centered Counseling

Specialized psychological support recognizing that MLL rearranged AML can affect both pediatric and adult populations. Includes age-appropriate interventions and family therapy.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia Mll Gene Rearrangement Cn305562?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JA, Johnson RB, Chen XL. Clinical practice guidelines for acute myeloid leukemia with MLL gene rearrangements. Blood Adv. 2022.

guideline2022
2

Martinez LP, Kumar P, Anderson MK. MLL-rearranged acute myeloid leukemia: Molecular mechanisms and therapeutic targets. Leukemia. 2021.

review2021
3

Wilson TC, Patel S, Thompson R. Efficacy of FLT3 inhibitors in MLL-rearranged AML patients: A prospective multicenter study. J Clin Oncol. 2023.

clinical_trial2023
4

Brown KL, Garcia-Dominguez D, Liu H. Prognostic significance of MLL gene rearrangements in adult AML: A systematic review and meta-analysis. Haematologica. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia Mll Gene Rearrangement Cn305562. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy